New: NCI-funded clinical trial search
Mednet Logo
CommunityRadiation Oncology

Is there evidence supporting the role of SBRT in the management of oligometastatic stage IV NSCLC?

How does this apply to patients with brain-only oligometastases?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Texas at Tyler
Answered on

Yes. I would look at a great trial from Wake Forest, looking at consolidative radiotherapy after 3-6 cycles of platinum-based chemotherapy, followed by observation, so chemotherapy, then radiotherapy, then observation (no maintenance chemotherapy). The trial occurred from 2010 to 2015. This single-a...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Texas at Tyler
Answered on · Updated on

To define a population undergoing active treatment with effective systemic agents that might benefit from LCT requires a nuanced approach, given that tumor response may operate in a time-dependent manner depending on the systemic agent used. The definition of oligometastasis: site, volume, and numbe...

Join for free or sign in to see the full answer